FI951387L - Sulfonamidokarbonyylipyridiini-2-karboksyylihappoesteriamidit sekä niiden pyridiini-N-oksidit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä - Google Patents
Sulfonamidokarbonyylipyridiini-2-karboksyylihappoesteriamidit sekä niiden pyridiini-N-oksidit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä Download PDFInfo
- Publication number
- FI951387L FI951387L FI951387A FI951387A FI951387L FI 951387 L FI951387 L FI 951387L FI 951387 A FI951387 A FI 951387A FI 951387 A FI951387 A FI 951387A FI 951387 L FI951387 L FI 951387L
- Authority
- FI
- Finland
- Prior art keywords
- sulfonamidocarbonylpyridine
- pharmaceuticals
- pyridine
- oxides
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4410480A DE4410480A1 (de) | 1994-03-25 | 1994-03-25 | Sulfonamidocarbonylpyridin-2-carbonsäureesteramide sowie ihre Pyridin-N-oxide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI951387A0 FI951387A0 (fi) | 1995-03-23 |
| FI951387A7 FI951387A7 (fi) | 1995-09-26 |
| FI951387L true FI951387L (fi) | 1995-09-26 |
Family
ID=6513896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI951387A FI951387L (fi) | 1994-03-25 | 1995-03-23 | Sulfonamidokarbonyylipyridiini-2-karboksyylihappoesteriamidit sekä niiden pyridiini-N-oksidit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5620996A (cs) |
| EP (1) | EP0673932B1 (cs) |
| JP (1) | JPH07278110A (cs) |
| KR (1) | KR950032126A (cs) |
| AT (1) | ATE193702T1 (cs) |
| AU (1) | AU688450B2 (cs) |
| CA (1) | CA2145475A1 (cs) |
| CZ (1) | CZ289536B6 (cs) |
| DE (2) | DE4410480A1 (cs) |
| DK (1) | DK0673932T3 (cs) |
| ES (1) | ES2146676T3 (cs) |
| FI (1) | FI951387L (cs) |
| GR (1) | GR3033706T3 (cs) |
| HU (1) | HUT72598A (cs) |
| NO (1) | NO304265B1 (cs) |
| NZ (1) | NZ270784A (cs) |
| PL (1) | PL180678B1 (cs) |
| PT (1) | PT673932E (cs) |
| ZA (1) | ZA952409B (cs) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT798296E (pt) * | 1996-03-21 | 2004-04-30 | Lonza Ag | Processo para a producao de arilamidas de acidos carboxilicos heteroaromaticos |
| SK283920B6 (sk) | 1996-03-28 | 2004-05-04 | Lonza Ag | Spôsob výroby arylamidov heteroaromatických karboxylových kyselín |
| ATE189815T1 (de) * | 1996-05-09 | 2000-03-15 | Lonza Ag | Verfahren zur herstellung von arylamiden heteroaromatischer carbonsäuren |
| CA2209392C (en) * | 1996-07-23 | 2007-02-20 | Yves Bessard | Process for preparing pyridinecarboxylic esters |
| US6169183B1 (en) | 1996-07-23 | 2001-01-02 | Lonza, Ltd. | Process for preparing pyridinecarboxylic esters |
| DE19742951A1 (de) | 1997-09-29 | 1999-04-15 | Hoechst Schering Agrevo Gmbh | Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung |
| EP2295060B1 (en) | 2001-12-06 | 2018-10-31 | Fibrogen, Inc. | Treatment or prevention of ischemic or hypoxic conditions |
| WO2003053997A2 (en) | 2001-12-06 | 2003-07-03 | Fibrogen, Inc. | Methods of increasing endogenous erythropoietin (epo) |
| US7618940B2 (en) * | 2002-12-06 | 2009-11-17 | Fibrogen, Inc. | Fat regulation |
| US8124582B2 (en) * | 2002-12-06 | 2012-02-28 | Fibrogen, Inc. | Treatment of diabetes |
| US8614204B2 (en) | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
| EP1491527A1 (en) * | 2003-06-25 | 2004-12-29 | Bayer CropScience GmbH | Process for preparing acylsulfamoylbenzamides |
| CN101242817B (zh) | 2005-06-15 | 2016-08-31 | 菲布罗根公司 | HIF1α调节剂在治疗癌症中的用途 |
| ES2619522T3 (es) * | 2006-03-30 | 2017-06-26 | Lg Electronics, Inc. | Un método y un aparato para descodificar/codificar una señal de video multivisión |
| EP3026044B8 (en) | 2006-06-26 | 2018-12-19 | Akebia Therapeutics, Inc. | Prolyl hydroxylase inhibitors and methods of use |
| US8962530B2 (en) * | 2007-06-27 | 2015-02-24 | Regents Of The University Of Colorado | Inflammatory bowel disease therapies |
| NO2686520T3 (cs) | 2011-06-06 | 2018-03-17 | ||
| WO2014200773A2 (en) | 2013-06-13 | 2014-12-18 | Akebia Therapeutics , Inc. | Compositions and methods for treating anemia |
| CN105916502A (zh) | 2013-11-15 | 2016-08-31 | 阿克比治疗有限公司 | {[5-(3-氯苯基)-3-羟基吡啶-2-羰基]氨基}乙酸的固体形式，其组合物和用途 |
| WO2016118858A1 (en) | 2015-01-23 | 2016-07-28 | Akebia Therapeutics, Inc. | Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof |
| NZ735973A (en) | 2015-04-01 | 2023-06-30 | Akebia Therapeutics Inc | Compositions and methods for treating anemia |
| CN105130888A (zh) * | 2015-10-09 | 2015-12-09 | 中国药科大学 | 炔基吡啶类脯氨酰羟化酶抑制剂、其制备方法和医药用途 |
| US11713298B2 (en) | 2018-05-09 | 2023-08-01 | Akebia Therapeutics, Inc. | Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid |
| US11524939B2 (en) | 2019-11-13 | 2022-12-13 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0541042A1 (de) * | 1991-11-05 | 1993-05-12 | Hoechst Aktiengesellschaft | Pyridin-2,4- und 2,5-dicarbonsäureamide und deren Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel |
| TW352384B (en) * | 1992-03-24 | 1999-02-11 | Hoechst Ag | Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals |
-
1994
- 1994-03-25 DE DE4410480A patent/DE4410480A1/de not_active Withdrawn
-
1995
- 1995-03-13 AT AT95103582T patent/ATE193702T1/de not_active IP Right Cessation
- 1995-03-13 PT PT95103582T patent/PT673932E/pt unknown
- 1995-03-13 EP EP95103582A patent/EP0673932B1/de not_active Expired - Lifetime
- 1995-03-13 DK DK95103582T patent/DK0673932T3/da active
- 1995-03-13 ES ES95103582T patent/ES2146676T3/es not_active Expired - Lifetime
- 1995-03-13 DE DE59508440T patent/DE59508440D1/de not_active Expired - Fee Related
- 1995-03-23 AU AU15043/95A patent/AU688450B2/en not_active Ceased
- 1995-03-23 CZ CZ1995734A patent/CZ289536B6/cs not_active IP Right Cessation
- 1995-03-23 FI FI951387A patent/FI951387L/fi unknown
- 1995-03-23 NZ NZ270784A patent/NZ270784A/en unknown
- 1995-03-24 NO NO951149A patent/NO304265B1/no not_active IP Right Cessation
- 1995-03-24 ZA ZA952409A patent/ZA952409B/xx unknown
- 1995-03-24 HU HU9500864A patent/HUT72598A/hu unknown
- 1995-03-24 US US08/410,610 patent/US5620996A/en not_active Expired - Fee Related
- 1995-03-24 CA CA002145475A patent/CA2145475A1/en not_active Abandoned
- 1995-03-24 PL PL95307847A patent/PL180678B1/pl unknown
- 1995-03-24 JP JP7065926A patent/JPH07278110A/ja active Pending
- 1995-03-25 KR KR1019950006805A patent/KR950032126A/ko not_active Ceased
-
2000
- 2000-06-16 GR GR20000401396T patent/GR3033706T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE59508440D1 (de) | 2000-07-13 |
| KR950032126A (ko) | 1995-12-20 |
| JPH07278110A (ja) | 1995-10-24 |
| CA2145475A1 (en) | 1995-09-26 |
| NO951149D0 (no) | 1995-03-24 |
| HUT72598A (en) | 1996-05-28 |
| NZ270784A (en) | 1997-02-24 |
| EP0673932A1 (de) | 1995-09-27 |
| PL180678B1 (pl) | 2001-03-30 |
| AU1504395A (en) | 1995-10-05 |
| CZ289536B6 (cs) | 2002-02-13 |
| DE4410480A1 (de) | 1995-09-28 |
| ZA952409B (en) | 1995-11-28 |
| FI951387A0 (fi) | 1995-03-23 |
| ES2146676T3 (es) | 2000-08-16 |
| FI951387A7 (fi) | 1995-09-26 |
| DK0673932T3 (da) | 2000-09-18 |
| CZ73495A3 (en) | 1995-11-15 |
| PL307847A1 (en) | 1995-10-02 |
| US5620996A (en) | 1997-04-15 |
| EP0673932B1 (de) | 2000-06-07 |
| AU688450B2 (en) | 1998-03-12 |
| ATE193702T1 (de) | 2000-06-15 |
| NO304265B1 (no) | 1998-11-23 |
| PT673932E (pt) | 2000-09-29 |
| NO951149L (no) | 1995-09-26 |
| HK1011973A1 (en) | 1999-07-23 |
| GR3033706T3 (en) | 2000-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI951387L (fi) | Sulfonamidokarbonyylipyridiini-2-karboksyylihappoesteriamidit sekä niiden pyridiini-N-oksidit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
| FI951386A7 (fi) | Sulfanamidokarbonyylipyridiini-2-karboksyylihappoamidit sekä niiden pyridiini-N-oksidit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
| FI935513A7 (fi) | Karboksyylihappojohdannaiset, näitä sistältävät lääkeaineet ja menetelmä niiden valmistamiseksi | |
| FI964395L (fi) | Uudet erytromysiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
| FI963298L (fi) | Hydrokseemihappo- ja karboksyylihappojohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö | |
| FI904419A7 (fi) | 3-(1-substituoituja-4-piperatsinyyli)-1H-indatsoleja, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
| FI955913A7 (fi) | Uudet erytromysiinijohdannaiset, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
| FI942074A7 (fi) | nor-sappijohdannaisia, menetelmä niiden valmistamiseksi ja näiden yhdisteiden käyttö lääkeaineina | |
| FI971529L (fi) | Uudet karboksyylihappojohdannaiset, niiden valmistus ja käyttö | |
| FI952230L (fi) | Uusi aryylipropaanijohdannainen, menetelmä sen valmistamiseksi ja sen käyttö analgeettisena aineena | |
| IL131751A0 (en) | Aryl-or heteroarylsulfonamide substituted hydroxamic acid derivatives process for their preparation and their use as pharmaceuticals | |
| EE9800265A (et) | Erütromütsiini derivaadid, nende valmistamismeetod ja kasutamine ravimitena | |
| FI902248A7 (fi) | N-heteroaryyli-4-kinoliiniamiineja, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
| FI970094L (fi) | Substituoidut bentsamidiinit, niiden valmistus ja käyttö lääkeaineena | |
| FI903819A7 (fi) | 1,3-dihydro-1-(pyridinyyliamino)-2H-indol-2-oneja, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineina | |
| FI902850A7 (fi) | N-heteroaryylipuriini-6-amiineja, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineina | |
| FI951388A7 (fi) | Substituoidut heterosykliset karboksyylihappoamidiesterit, niiden valmistus ja niiden käyttö lääkeaineina | |
| FI952324A7 (fi) | Heterosykliset karbamaatit, menetelmä niiden valmistamiseksi ja lääkke et | |
| FI934611A7 (fi) | Substituoituja (pyridinyyliamino)-bentsisoksatsoleja ja -bentso(b)tiofeenejä, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineina | |
| FI964901L (fi) | Menetelmä alfa-metoksi-iminokarboksyylihappometyyliamidien valmistamiseksi ja menetelmässä käytettyjä välituotteita | |
| FI951631L (fi) | Substituoituja kynureniinejä, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä | |
| EE04398B1 (et) | Asendatud 1,2,3,4,5,6-heksahüdro-2,6-metano-3-bensasotsiin-10-oolid, nende valmistamise meetod ja kasutamine ravimitena | |
| EE9600023A (et) | Fenüültsükloheksüülkarboksüülhappeamiidid, nende valmistamismeetod, kasutamine ravimite valmistamiseks, nimetatud ühendeid sisaldavad ravimid ja nende valmistamismeetod | |
| HU9501041D0 (en) | Peptide-boronic acid derivatives, process for producing them and pharmaceutical application thereof | |
| FI903818A7 (fi) | 1-(pyridinyyliamino)-2-pyrrolidoneja, menetelmä niiden valmistamiseksija niiden käyttö lääkkeinä |